Mathijs Steegstra

Executive Vice President Quality and Drug Regulatory Affairs

Dr. Mathijs.R. Steegstra is a strategic & analytical thinker, abler to keep an overview, strong commercial focus. He joined MSP Group as Global Quality and DRA in February 2020.

In his career as regulatory affairs professional he has acquired a lot of experience in pharma, OTC’s, and devices, handling new filings and life cycle management via national, MRP/DCP, or Centralized Procedures, as well as quality management as an EU QP.

Mr. Steegstra held his position as Director Regulatory Affairs in various pharmaceutical companies such as Amneal Pharmaceuticals Company GmbH and Actavis S.àr.l. in Zug, Switzerland.

Mr. Steegstra has a graduate degree as a MSc. Pharmacy, specialization in molecular pharmacology, and as a pharmacist from the Rijksuniversiteit Groningen.

During his career, he has published several publications, served on many committees, and continued his education.